4D Biomaterials has completed a £1.6M funding round from DSW Ventures and Mercia.
19 July 2021
19 July 2021
Total investments received (USD): 6.53m
Round value (USD): 2.21m
Round investors:
DSW Ventures
Mercia Ventures
Company: 4D Medicine
Industry:
Health services
Manufacturing
Related deals
Shift Bioscience was pre-seeded by Healthspan Capital et al
Investments
16 December 2021
Baseimmune secured $4.8 million in a round led by Hoxton Ventures
Investments
01 November 2021
Hexarad raised £2.3M from Foresight Group.
Investments
07 September 2021
Grow Group raises £3.5M via Seedrs
Investments
02 September 2021
Chromacity raised £1.2 million from Kelvin Capital, EOS and Scottish Enterprise, and ESM Investments.
Investments
10 August 2021
Belgium
Netherlands
Austria
Switzerland
Denmark
Estonia
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain